ViƱa, Novielyn .
HRN: 25-10-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2024
CEFUROXIME 500MG (TAB)
05/23/2024
05/30/2024
PO
500 Mg
BID
S/P Completion Curettage
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes